These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18519751)

  • 1. Involvement of hepcidin in the anemia of multiple myeloma.
    Sharma S; Nemeth E; Chen YH; Goodnough J; Huston A; Roodman GD; Ganz T; Lichtenstein A
    Clin Cancer Res; 2008 Jun; 14(11):3262-7. PubMed ID: 18519751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepcidin and multiple myeloma related anemia.
    Cucuianu A; Patiu M; Rusu A
    Med Hypotheses; 2006; 66(2):352-4. PubMed ID: 16226391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
    Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
    Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients.
    Malyszko J; Malyszko JS; Mysliwiec M
    Transplant Proc; 2009 Oct; 41(8):3056-9. PubMed ID: 19857675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin and iron deficiency in pre-kidney transplant patients.
    Sancho A; Pastor MC; Troya M; Bonal J; Bayés B; Morales-Indiano C; Lauzurica R; Romero R
    Transplant Proc; 2009; 41(6):2079-81. PubMed ID: 19715836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peripheral blood monocyte hepcidin in patients with multiple myeloma is associated with anemia of chronic disease].
    Han X; Zhou DB; Duan MH; Wang X; Zhang JP; Zhao YQ; Shen T; Wu YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):403-9. PubMed ID: 23628042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis.
    Abdel-Khalek MA; El-Barbary AM; Essa SA; Ghobashi AS
    J Rheumatol; 2011 Oct; 38(10):2153-9. PubMed ID: 21885483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity.
    Alexandrakis MG; Passam FH; Sfiridaki A; Kandidaki E; Roussou P; Kyriakou DS
    Am J Hematol; 2003 Apr; 72(4):229-33. PubMed ID: 12666132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of serum vascular endothelial growth factor and interleukin-6 in multiple myeloma].
    Shen JK; Dong LH; Qi H; Zhang GS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):68-71. PubMed ID: 15871192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A possible role of hepcidin in the pathogenesis of anemia in heart allograft recipients.
    Przybylowski P; Malyszko J; Malyszko JS
    Transplant Proc; 2010 Jun; 42(5):1803-7. PubMed ID: 20620527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM
    Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia in heart and kidney allograft recipients: is there a role for hepcidin?
    Przybylowski P; Malyszko J; Malyszko JS; Koc-Zorawska E; Sadowski J; Mysliwiec M
    Transplant Proc; 2010 Dec; 42(10):4255-8. PubMed ID: 21168677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C.
    Tsochatzis E; Papatheodoridis GV; Koliaraki V; Hadziyannis E; Kafiri G; Manesis EK; Mamalaki A; Archimandritis AJ
    J Viral Hepat; 2010 Nov; 17(11):800-6. PubMed ID: 20002304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH.
    Bekri S; Gual P; Anty R; Luciani N; Dahman M; Ramesh B; Iannelli A; Staccini-Myx A; Casanova D; Ben Amor I; Saint-Paul MC; Huet PM; Sadoul JL; Gugenheim J; Srai SK; Tran A; Le Marchand-Brustel Y
    Gastroenterology; 2006 Sep; 131(3):788-96. PubMed ID: 16952548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anemia of ageing is not associated with increased plasma hepcidin levels.
    Lee P; Gelbart T; Waalen J; Beutler E
    Blood Cells Mol Dis; 2008; 41(3):252-4. PubMed ID: 18676162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of thalidomide on interleukin-6 and its transmission in multiple myeloma patients].
    Li J; Luo S; Hong W; Zhou Z; Zou W
    Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):254-6. PubMed ID: 12515619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepcidin, interleukin-6 and hematological iron markers in males before and after heart surgery.
    Hoppe M; Lönnerdal B; Hossain B; Olsson S; Nilsson F; Lundberg PA; Rödjer S; Hulthén L
    J Nutr Biochem; 2009 Jan; 20(1):11-6. PubMed ID: 18495462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of hepcidin: insights from biochemical analyses on human serum samples.
    Kemna EH; Kartikasari AE; van Tits LJ; Pickkers P; Tjalsma H; Swinkels DW
    Blood Cells Mol Dis; 2008; 40(3):339-46. PubMed ID: 18023212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepcidin and Plasmodium falciparum malaria in anemic school children in Mali].
    Ayoya MA; Stoltzfus RJ; Spiekermann-Brouwer GM; Nemeth E; Traoré AK; Ganz T; Garza C
    Bull Soc Pathol Exot; 2009 Oct; 102(4):219-20. PubMed ID: 19950537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.
    Kuku I; Bayraktar MR; Kaya E; Erkurt MA; Bayraktar N; Cikim K; Aydogdu I
    Mediators Inflamm; 2005 Aug; 2005(3):171-4. PubMed ID: 16106104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.